Early results of new studies suggest GlaxoSmithKline Plc’s antidepressant Paxil increases the risk of birth defects when women take it during the first three months of pregnancy, the Food and Drug ...

After more than a decade of controversy surrounding a 2001 clinical trial led by a Brown professor on the effects of the antidepressant Paxil, a reanalysis of the original data claims the drug is no ...

I dread public speaking. I get nervous on first dates. I hate to be called on in classes or meetings. In short, I’m shy. Not debilitatingly so. I’m guessing many of you are no different. I’ve often ...

Keep up-to-date with everything that happens in your world.

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

Sept. 28, 2005 — The U.S. Food and Drug Administration (FDA) and GlaxoSmithKline have warned healthcare professionals via letter regarding the potential risk of major congenital malformations in ...

Washington, DC - The antidepressant Paxil may raise the risk of suicidal behavior in young adults, GlaxoSmithKline and the Food and Drug Administration warned Friday in a letter to doctors. The ...

WASHINGTON (AP) -- The antidepressant Paxil may raise the risk of suicidal behavior in young adults, GlaxoSmithKline and the Food and Drug Administration warned Friday in a letter to doctors. The ...